Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a prospective, non-randomized data collection study to evaluate the performance of the Masimo INVSENSOR00063 in obtaining temperature measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2023
CompletedFirst Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 28, 2023
CompletedResults Posted
Study results publicly available
July 10, 2023
CompletedOctober 31, 2025
June 1, 2023
7 days
March 15, 2023
May 11, 2023
October 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy of Temperature Measurements Using Masimo INVSENSOR00063
Masimo INVSENSOR00063 temperature measurements will be compared to reference temperature measurements. Accuracy of Masimo INVSENSOR00063 will be measured using clinical bias, limits of agreement and repeatability.
About 15-30 minutes
Study Arms (1)
Masimo INVSENSOR00063
EXPERIMENTALAll subjects are enrolled into this arm and will have temperature measurements obtained.
Interventions
Masimo INVSENSOR00063 will be used to measure temperature
Eligibility Criteria
You may qualify if:
- Participant age ≥ 1 year
- Afebrile or febrile at time of enrollment: For febrile subjects, ≥ 99.5 F/ 37.5 C for sublingual temperature reference; ≥ 100.4 F/ 38 C for temporal artery temperature reference.
- English-or Spanish-speaking patient or parent/Legal Guardian
You may not qualify if:
- Participants deemed not suitable for the study at the discretion of the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ascada Research
Fullerton, California, 92835, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Chelsea Frank
- Organization
- Masimo
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2023
First Posted
March 28, 2023
Study Start
February 23, 2023
Primary Completion
March 2, 2023
Study Completion
March 2, 2023
Last Updated
October 31, 2025
Results First Posted
July 10, 2023
Record last verified: 2023-06